© 1997 by European Society of Cardiology
Copyright © 1997, European Society of Cardiology
Changes in collagen phenotypes during progression and regression of cardiac hypertrophy
Department of Molecular Cardiology (FF4-09), Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
* Corresponding author. Tel. (+1-216) 4442056; Fax. (+1-216) 4449263; E-mail sens@ccsmtp.ccf.org
Objective: Excessive deposition of collagen has been implied to be responsible for abnormal stiffness and altered cardiac function during hypertrophy and heart failure. In the present paper we studied the changes in collagen and their phenotypes during development of cardiac hypertrophy in spontaneously hypertensive rats (SHR) compared to age- and sex-matched Wistar Kyoto (WKY). We also studied the changes in collagen after regression of hypertrophy, with antihypertensive therapy with ACE inhibitors, captopril (C) and lisinopril (L). Method: Collagen was extracted from the heart tissue by cyanogen bromide (CNBr) digestion. Collagen phenotypes were separated and quantified by SDS–polyacrylamide gel electrophoresis. The transcript levels (mRNA) of collagen phenotypes were determined by Northern analysis. Results: Our studies showed that the ventricular collagen and their phenotypes did not alter in SHR during the first 6 months of progression of hypertrophy when compared to WKY. After 40 weeks, however, in SHR there was an unexpected rise in collagen content and the distribution of collagen phenotype differs compared to WKY, especially during the chronic phase of hypertrophy (65 weeks of age). In WKY during the aging process there was a gradual increase in type III collagen, whereas in SHR it plateaus after 40 weeks of age. Treatment with antihypertensive drugs captopril and lisinopril showed a similar degree of reduction in blood pressure (p<0.001), regressed hypertrophy (p<0.001), and reduced collagen, whereas decrease in type I to III ratio was found with captopril only, but not with lisinopril. This decrease in type I to III ratio due to captopril treatment is primarily due to an increase in type III collagen (both protein and transcript level) in SHR. Conclusion: Our data showed, for the first time, that during the chronic phase of hypertrophy in SHR there is a gradual reduction in type I to III ratio, primarily due to a lack of increase in type III collagen during chronic phase of hypertrophy. This suggests that quality of collagen is an important factor in determining the degree of cardiac stiffness. Our data also showed that not all ACE inhibitors have similar actions on collagen phenotype production. This suggests that perhaps the mechanism of action of ACE inhibitors on collagen are independent of its effect on angiotensin II formation.
KEYWORDS Collagen phenotypes; Captopril; Lisinopril; Angiotensin II; Regression of Hypertrophy; Rat
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Imamura, A. Kanematsu, S. Yamamoto, Y. Kimura, I. Kanatani, N. Ito, Y. Tabata, and O. Ogawa Basic fibroblast growth factor modulates proliferation and collagen expression in urinary bladder smooth muscle cells Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1007 - F1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Hwang, G. Cirrincione, D. P. Thomas, R. J. McCormick, and M. O. Boluyt Aldosterone Antagonism Fails to Attenuate Age-Associated Left Ventricular Fibrosis J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2007; 62(4): 382 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Alwardt, Q. Yu, H. L. Brooks, M. R. McReynolds, R. Vazquez, R. R. Watson, and D. F. Larson Comparative effects of dehydroepiandrosterone sulfate on ventricular diastolic function with young and aged female mice Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R251 - R256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Iwasaki, K. Mukasa, M. Yoneda, S. Ito, Y. Yamada, Y. Mori, N. Fujisawa, T. Fujisawa, K. Wada, H. Sekihara, et al. Marked attenuation of production of collagen type I from cardiac fibroblasts by dehydroepiandrosterone Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1222 - E1228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Arbab-Zadeh, E. Dijk, A. Prasad, Q. Fu, P. Torres, R. Zhang, J. D. Thomas, D. Palmer, and B. D. Levine Effect of Aging and Physical Activity on Left Ventricular Compliance Circulation, September 28, 2004; 110(13): 1799 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sarkar, E. Vellaichamy, D. Young, and S. Sen Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H107 - H117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B. J. Mancini, B. Dahlof, and J. Diez Surrogate Markers for Cardiovascular Disease: Structural Markers Circulation, June 29, 2004; 109(25_suppl_1): IV-22 - IV-30. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xu, I. A Arenas, S. J Armstrong, and S. T Davidge Estrogen modulation of left ventricular remodeling in the aged heart Cardiovasc Res, February 1, 2003; 57(2): 388 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Bayraktutan, Z.-K. Yang, and A. M Shah Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rat Cardiovasc Res, June 1, 1998; 38(3): 719 - 726. [Abstract] [Full Text] [PDF]
|
|